For the Inventor, By the Inventor

Enter assignee name

Zhejiang, China

Betta Pharmaceuticals Co., Ltd.

USPTO Granted Patents = 19

CIPO Patents = 8

EPO Patents = 13

Forward Citations = 16

Loading Chart...

Loading Chart...

37 inventors (with patents filed for the assignee):

Lieming Ding (12 out of 14 patents)

Shaojing Hu (11 out of 14 patents)

Wei Long (11 out of 18 patents)

4. Yinxiang Wang (8 out of 15 patents)

5. Jiabing Wang (7 out of 8 patents)

6. Fei Wang (7 out of 91 patents)

7. Yanping Wang (4 out of 17 patents)

8. Fenlai Tan (4 out of 8 patents)

9. Yiqian Wang (3 out of 3 patents)

10. Xiaofeng Xu (3 out of 3 patents)

11. Yunyan Hu (3 out of 15 patents)

12. Cunbo Ma (3 out of 8 patents)

13. Hong Cao (3 out of 10 patents)

14. Xiangyong Liu (3 out of 4 patents)

15. Yan Xu (2 out of 52 patents)

19 patents: Sort by Forward Citations

1. 12187713 - Immunomodulators, compositions and methods thereof (2025-01-07),

2. 12043622 - Crystal form of compound for inhibiting the activity of CDK4/6 and use thereof (2024-07-23),

3. 11845762 - Compound functioning as bromodomain protein inhibitor, and composition (2023-12-19),

4. 11466034 - Compound functioning as bromodomain protein inhibitor, and composition (2022-10-11),

5. 11466013 - ERK inhibitor and use thereof (2022-10-11),

6. 11365196 - FGFR inhibitor and application thereof (2022-06-21),

7. 11053238 - Benzimidazole derivatives, preparation methods and uses thereof (2021-07-06),

8. 10577364 - Crystalline form of fused pyridine derivative's maleate and uses thereof (2020-03-03),

9. 10059688 - Protein tyrosine kinase modulators and methods of use (2018-08-28),

10. 9783524 - Protein tyrosine kinase modulators and methods of use (2017-10-10),

11. 9688687 - Polymorphic forms of icotinib phosphate and uses thereof (2017-06-27),

12. 9617257 - Fused pyridine derivatives useful as c-Met tyrosine kinase inhibitors (2017-04-11),

13. 9611272 - Polymorphic forms of icotinib and uses thereof (2017-04-04),

14. 9505774 - Polymorphic forms of icotinib maleate and uses thereof (2016-11-29),

15. 9487570 - Glucagon like peptide analogs, composition, and method of use (2016-11-08),

Betta Pharmaceuticals Co., Ltd. is a leading global biopharmaceutical company dedicated to discovering, developing, and commercializing innovative therapies for serious diseases. With a strong focus on research and development, Betta Pharmaceuticals strives to bring impactful solutions to patients worldwide. Through their state-of-the-art facilities and collaborative partnerships, they aim to advance the healthcare sector and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

19 Patents

#42 in Zhejiang

#1,376 in China

#31,731 in the World

Zhejiang, China

Betta Pharmaceuticals Co., Ltd.

Forward Citations = 16

37 inventors:

Lieming Ding (12 out of 14 patents)

Shaojing Hu (11 out of 14 patents)

Wei Long (11 out of 18 patents)

4. Yinxiang Wang (8 out of 15 patents)

5. Jiabing Wang (7 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…